IRIS
RENDA, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.901
EU - Europa 3.383
AS - Asia 2.319
SA - Sud America 244
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 1
Totale 9.875
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.865
SG - Singapore 913
CN - Cina 718
IE - Irlanda 687
UA - Ucraina 627
IT - Italia 530
TR - Turchia 478
SE - Svezia 475
GB - Regno Unito 262
DE - Germania 238
BR - Brasile 229
FR - Francia 181
FI - Finlandia 142
RU - Federazione Russa 120
IN - India 68
HK - Hong Kong 36
AT - Austria 24
BE - Belgio 22
CA - Canada 22
IR - Iran 22
PL - Polonia 21
VN - Vietnam 18
NL - Olanda 12
BD - Bangladesh 11
EU - Europa 10
CZ - Repubblica Ceca 9
JP - Giappone 9
IQ - Iraq 8
MX - Messico 7
EG - Egitto 6
ES - Italia 6
IL - Israele 6
JO - Giordania 5
LT - Lituania 5
RO - Romania 5
ZA - Sudafrica 5
EC - Ecuador 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
DK - Danimarca 3
KR - Corea 3
OM - Oman 3
VE - Venezuela 3
CR - Costa Rica 2
EE - Estonia 2
GE - Georgia 2
HU - Ungheria 2
KZ - Kazakistan 2
PH - Filippine 2
RS - Serbia 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GR - Grecia 1
GT - Guatemala 1
ID - Indonesia 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 9.875
Salva come PNG Salva come JPEG
Città #
Jacksonville 756
Dublin 668
Chandler 649
Singapore 589
Princeton 337
Izmir 224
Nanjing 201
Southend 196
Ashburn 155
Altamura 118
Dearborn 117
Santa Clara 117
Cambridge 116
Wilmington 112
Beijing 111
The Dalles 103
Nanchang 87
Ann Arbor 79
Chieti 67
Los Angeles 53
Pescara 40
Boardman 39
Hebei 39
Shenyang 39
Woodbridge 38
Hong Kong 35
Kunming 35
New York 33
Munich 30
Tianjin 26
Washington 25
Augusta 24
Jiaxing 23
San Mateo 23
Brussels 22
Changsha 22
Grevenbroich 22
Norwalk 22
Leawood 20
Helsinki 18
Ardabil 17
Camerino 17
Teramo 17
Dong Ket 15
Falls Church 15
Kraków 15
Hangzhou 14
Guangzhou 12
São Paulo 12
Düsseldorf 11
Houston 11
Hefei 10
Lappeenranta 10
Nuremberg 10
Rome 10
Toronto 10
Milan 9
Moscow 9
Vienna 9
Bologna 8
Brno 8
Brooklyn 8
Lanzhou 8
Rio de Janeiro 8
Shanghai 8
Tokyo 8
Chicago 7
Frankfurt am Main 7
Seattle 7
Stockholm 7
Taizhou 7
Amsterdam 6
Atlanta 6
Bari 6
Belo Horizonte 6
Brasília 6
Council Bluffs 6
Jinan 6
Monmouth Junction 6
Mumbai 6
Turku 6
Amman 5
Cairo 5
Messina 5
Montreal 5
Roslyn Heights 5
Xi'an 5
Auburn Hills 4
Beersheba 4
Betim 4
Brindisi 4
Chennai 4
Dallas 4
Fort Worth 4
Fuzhou 4
L'aquila 4
Ningbo 4
Ottawa 4
Paris 4
Phoenix 4
Totale 5.896
Salva come PNG Salva come JPEG
Nome #
Increased left atrial size in obese children and its association with insulin resistance: a pilot study 136
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial 118
Response to "Pharmacodynamic Interaction Between Aspirin and Ibuprofen: A Plausible Mechanism of Aspirin Resistance" 117
Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents 116
Effects of endurance, resistance and neuro-muscular electrical stimulation trainings to the anthropometric and functional mobility domains in elderly 115
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy 111
Failure in evoking the trigeminal cardiac reflex by mandibular stretching in healthy volunteers 104
Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery 103
Intracardiac thrombi during warfarin anticoagulation - A case report and a brief literature review 97
The Role of Multimodality Cardiovascular Imaging in Peripartum Cardiomyopathy 97
Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions 93
La gestione del rischio tromboembolico nei pazienti con fibrillazione atriale in Italia: Dati al follow-up del Registro Europeo PREFER in AF 93
Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences 92
Genetic determinants of blood pressure responses to caffeine drinking 89
Aneurisma coronarico: scoperta generalmente casuale, prognosi sempre severa? 89
Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects 88
Genetic determinants of cognitive responses to caffeine drinking identified from a double-blind, randomized, controlled trial 87
Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin 86
Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease 86
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease 85
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 84
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 84
Coffee: Health Effects 83
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 83
Facilitated PCI: Rationale, current evidence, open questions and future directions 82
The left atrial appendage: from embryology to prevention of thromboembolism 82
INCREASED THROMBOXANE PRODUCTION BY MONOCYTE PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-2 IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. 81
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease 81
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies 81
Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillation ∗ 81
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial 79
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 78
Edoxaban for the Prevention of Thromboembolism in Patients with Atrial Fibrillation and Bioprosthetic Valves 77
Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF 76
Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries 76
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects 75
Cardiovascular effects of caffeine during cognitive tasks 75
Incomplete suppression of platelet COX-1 activity associated with aspirin-resistant thromboxane biosynthesis in acute coronary syndromes 74
Cardiovascular and psychological reactivity after caffeine consumption 74
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper 74
EFFECTS OF NIMESULIDE ON CONSTITUTIVE AND INDUCIBLE PROSTANOID BIOSYNTHESIS IN MAN. 73
Non-vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation - An Updated Meta-analysis 73
Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy 73
The legacy of ISCHEMIA 73
Dose- Dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects. 72
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W 72
Celecoxib, ibuprofen and the antiplatelet effect of aspirin in patients with osteoarthritis and chronic stable angina 72
An early decline of collateral circulation parallels myocardial ischaemia during percutaneous coronary intervention: a drawback of recanalization of chronic coronary occlusions? 72
Antithrombotic therapy in atrial fibrillation: state of the art and perspectives. 72
Echocardiographic screening for the anomalous aortic origin of coronary arteries 72
New anticoagulants for atrial fibrillation 71
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 71
Prognostic significance of noncardiac syncope in the general population: A systematic review and meta-analysis 70
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation 70
Atrial and left atrial appendage thrombosis in patients with atrial fibrillation: from pathophysiology to treatment 70
Blood pressure modifications after caffeine intake during cognitive tasks 69
Ambulatory blood pressure and risk of new-onset atrial fibrillation in treated hypertensive patients 69
AF: current and forthcoming antithrombotic therapies 69
Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry 68
Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study 68
CHA2DS2VASc score and adverse outcomes in middle-aged individuals without atrial fibrillation 68
Enhanced thromboxane biosynthesis in patients with colorectal and lung cancer 67
MECHANISMS OF ISOPROSTANE BIOSYNTHESIS IN HUMANS 66
Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects 66
Systolic and diastolic dysfunction occurs in newly diagnosed patients with hypertension and high systolic blood pressure variability 66
Systolic and diastolic dysfunction occurs in newly diagnosed patients with hypertension and high systolic blood pressure variability 65
Prognostic Significance of Chest Imaging by LUS and CT in COVID-19 Inpatients: The ECOVID Multicenter Study 64
Prognostic value of non-resistant and resistant masked uncontrolled hypertension detected by ambulatory blood pressure monitoring 64
Measurements of thromboxane production and their clinical significance in coronary heart disease 63
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 63
Antithrombotic management 63
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation 63
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 63
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis 63
ENHANCED CORTISOL SECRETION DOES NOT CONTROL ASPIRIN-INSENSITIVE THROMBOXANE BIOSYNTHESIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES 62
A comparison between unfractioned heparin and a low molecular weight heparin in cardiac surgery 62
Surgical bleeding after preoperative unfractionated heparin and low molecular weight heparin at coronary bypass surgery 62
Risk of Atrial Fibrillation in Masked and White Coat Uncontrolled Hypertension 62
Nutrigenetics of blood pressure responses to coffee drinking 61
The AVERROES Trial – Clinical Implications 61
Late coronary thrombosis after drug-eluting stent: stent vs patient-driven prescription of aspirin-clopidogrel combination 61
Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban 60
Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry 60
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions 60
EFFECTS OF NIMESULIDE ON CONSTITUTIVE AND INDUCIBLE PROSTANOID BIOSYNTHESIS IN HUMAN BEINGS 59
DIFFERENTIAL INHIBITION OF HUMAN PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-1 AND -2 BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 59
Autonomic nervous system dysfunction in obese children 59
Parmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects 59
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease 59
Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension 58
Circadianicity of hemostatic function and coronary vasomotion 58
Antithrombotic prophylaxis in the elderly with atrial fibrillation 58
Effect of fibrinogen concentration on the antiplatelet effect of tirofiban 58
ENHANCED CORTISOL SECRETION DOES NOT CONTROL ASPIRIN-INSENSITIVE THROMBOXANE BIOSYNTHESIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES. 57
Aspirin Resistance 57
P6223Relationship between platelet indices and future cardiovascular events: results from a population-based cohort study 57
Systolic blood pressure variability by non-invasive monitoring predicts intima-media thickness independent of absolute blood pressure levels 56
Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe. 56
A comparison between unfractionated heparin and a low molecular weight heparin in cardiac surgery 55
Ruolo del fibrinogeno e della conta piastrinica sull’inibizione dell’aggregazione piastrinica da parte dei farmaci anti-glicoproteina IIbIIIa 55
Totale 7.436
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.490
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 0 0 0 0 6
2020/2021947 130 4 144 25 112 170 22 22 36 102 142 38
2021/2022691 12 5 5 126 82 8 17 62 64 18 71 221
2022/20232.004 182 282 117 193 181 391 139 137 268 23 51 40
2023/2024961 75 17 57 11 51 299 221 46 11 29 30 114
2024/20252.343 168 442 348 83 61 96 88 124 314 192 303 124
Totale 10.507